Analysts Recommended this Stock: Akers Biosciences Inc (NASDAQ:AKER)

4

Akers Biosciences Inc (NASDAQ:AKER) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.

Akers Biosciences Inc (NASDAQ:AKER) lost -6.91 Percent and closed its previous trading session at $0.3. The stock traded with the average Volume of 3.15 Million at the end of last session.

Akers Biosciences Inc (NASDAQ:AKER) has the Market Capitalization of 28.7 Million. The Stock has its 52-week High of $1.820 and 52-Week Low of $0.120 and it touched its 52-week high on 10/13/17 and 52-Week Low on 12/22/17

.

The company reported its last earnings Actual EPS of $-0.2/share. While, the analyst predicted that the company could provide an EPS of $0.06/share. Hence the difference between Predicted EPS and Actual EPS reported is $-0.26/share which shows an Earnings Surprise of -433.3 Percent.

Sell side analysts plays vital role in buying and selling a stock where 0 analysts rated Akers Biosciences Inc (NASDAQ:AKER) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.98% where SMA50 and SMA200 are 7.2% and -27.99% respectively.

The company shows its Return on Assets (ROA) value of -90.7%. The Return on Equity (ROE) value stands at -114.8%. While it’s Return on Investment (ROI) value is -114%.

Akers Biosciences Inc (NASDAQ:AKER) currently has a Weekly Volatility of 17.19% percent while its Monthly Volatility is at 15.07% percent. While talking about Performance of the Stock, Akers Biosciences Inc currently has a Weekly performance of -26.72%, monthly performance percentage is -3.55 percent, Quarterly performance is -15.77 percent, 6 months performance shows a percent value of -46.08% and Yearly Performance is -65.3 percent.

Company Profile:

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company’s products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.

SHARE